Global Breast Cancer Diagnostics And Therapeutics Market Top Leading Players with Strategies and Forecast 2025
Global breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.4% during the forecast period. The growth of the market is attributed to the increasing prevalence of breast cancer and rising awareness in emerging countries such as India, China, and Malaysia. Furthermore, the introduction of new technology such as imaging technology and 3D mammography is also estimated to have a significant impact on the growth of the market. The global expenditure on breast cancer therapies and medicines is increasing very rapidly which leads to the high rates of diagnosis and treatment of breast cancer. However, the high cost of breast cancer drugs and surgeries across the developed countries are estimated to be the major constraints in the growth of the market. As per the American Cancer Society, breast cancer treatment can cost more than $100,000 in developed countries such as the US. The lack of awareness in women about breast cancer in developing countries is retraining the market.
To Request a Sample of our Report on Global
Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/breast-cancer-diagnostics-therapeutics-market
Global breast cancer diagnosis and therapeutics market are
segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer
type segment market is further classified into ductal carcinoma in-situ (DCIS),
invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC),
inflammatory breast cancer and others. In diagnostics technology, the segment
market is further classified into mammography, biopsy, position emission
tomography/Computed tomography, ultrasound, and others. The therapeutics
technology segment market is further segregated into chemotherapy, hormone
therapy, targeted therapy, and others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Breast Cancer Diagnostics And Therapeutics Market is
Available @ https://www.omrglobal.com/industry-reports/breast-cancer-diagnostics-therapeutics-market
Global Breast Cancer
Diagnostics And Therapeutics Segmentation
By Cancer Type
·
Ductal Carcinoma In-Situ (DCIS)
·
Invasive Ductal Carcinoma (IDC)
·
Triple Negative Breast Cancer (TNBC)
·
Inflammatory Breast Cancer
·
Others (Invasive lobular carcinoma)
By Diagnostics
·
Mammography
·
Biopsy
·
PET/CET
·
Ultrasound
·
Others (MRI)
By Therapeutics
·
Chemotherapy
·
Hormone Therapy
·
Targeted Therapy
·
Others (Radiation Therapy, Surgery)
Regional Analysis
·
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Italy
·
Spain
·
France
Rest of Europe
Asia-Pacific
·
China
·
India
·
Japan
·
Rest of Asia-Pacific
Rest of the World
Company Profiles
·
AbbVie Inc.
·
Agendia NV
·
AstraZeneca PLC
·
Astellas Pharma Inc.
·
Bayer AG
·
Bristol-Myers Squibb Co
·
Eisai Co., Ltd.
·
Eli Lilly and Co.
·
GlaxoSmithKline PLC
·
Halozyme, Inc
·
Hologic Inc.
·
Johnson & Johnson Services Inc.
·
Merck & Co., Inc.
·
Mylan NV
·
7Novartis International AG
·
Pfizer Inc.
·
F. Hoffmann-La Roche AG
·
Sanofi S.A.
·
Siemens Healthcare GmbH
·
Takeda Pharmaceutical Co. Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment